Symptoms include sudden convulsions, loss of consciousness, stiffening of muscles, or jerking movements
Researchers to reveal trial results for dual agonism in type 1 diabetes Experts, including Klara Klein, MD, PhD, will discuss the possible benefits of a glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist (GLP-1/GIP RA) for people living with type 1 diabetes
You receive10$ Friend receive10$
Levels naturally decline with age, stress, toxin exposure, and poor sleep, making supplementation essential for maintaining optimal wellness
Inzucchi SE, Bergenstal RM, Buse JB et al (2015) Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes